Bayer and Regeneron Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema
- Details
- Category: Bayer
![Bayer Bayer](/images/stories/logo/bayer.gif)
Amgen Establishes Commercial Operations in Brazil
- Details
- Category: Amgen
![Amgen Amgen](/images/stories/logo/amgen.gif)
Novartis sells global rights to Elidel®, a medicine to treat atopic dermatitis
- Details
- Category: Novartis
![Novartis Novartis](/images/stories/logo/novartis_b.gif)
FDA approves orphan drug vandetanib
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](/images/stories/logo/astrazeneca_b.gif)
Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation
- Details
- Category: Sanofi
![sanofi-aventis sanofi-aventis](/images/stories/logo/sanofi-aventis.gif)
Pfizer to Sell Capsugel to KKR
- Details
- Category: Pfizer
![Pfizer Pfizer](/images/stories/logo/pfizer_b.gif)
Boehringer Ingelheim's lead hepatitis C compound moves into phase III
- Details
- Category: Boehringer Ingelheim
![Boehringer Ingelheim Boehringer Ingelheim](/images/stories/logo/boehringeringelheim.gif)
More Pharma News ...
- GSK publishes payments for research, consulting and advising by US healthcare professionals
- Pfizer Posts Details Of Interactions With U.S. Health Care Professionals And Researchers In 2010
- REACT study to evaluate impact of Daxas® (roflumilast) in patients receiving standard COPD treatment
- Sanofi-aventis Announces Registration Statement for CVR Related to Genzyme Acquisition Declared Effective
- A new pharmaceutical candidate enters Lundbeck's development pipeline
- Merck and Its Employees to Donate to Japanese Relief Effort
- UK and US governments reach agreement over AstraZeneca tax matters